1
Clinical Trials associated with Staphylococcus aureus(Telum Therapeutics)A Single-center, Open-label, Phase Ib Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) With Different Dose in Healthy Adults Aged 18-70 Years in China
This is a single center, open-label phase1b clinical trial. The study will evaluate the safety and immunogenicity of an experimental recombinant staphylococcus aureus vaccine with different immunization schedules in healthy adults aged 18-70 years, including day 0-3-7, day 0/0-3-7, day 0/0-7 and day 0/0-7-14.
100 Clinical Results associated with Staphylococcus aureus(Telum Therapeutics)
100 Translational Medicine associated with Staphylococcus aureus(Telum Therapeutics)
100 Patents (Medical) associated with Staphylococcus aureus(Telum Therapeutics)
100 Deals associated with Staphylococcus aureus(Telum Therapeutics)